SCHEMBL12260002

SCHEMBL12260002

CS(=O)(=O)c1ccc2c(ccc3c2ccc2c4ccc(S(C)(=O)=O)cc4ccc23)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 2/20 0.47
AKR1C2 P52895 2/20 0.47
ATM Q13315 1/20 0.43
ENPP2 Q13822 2/20 0.43
G6PD P11413 1/20 0.42
IDE P14735 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
LMNA P02545 2/20 0.40
PTGS2 P35354 2/20 0.40
DPP4 P27487 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
CASP6 P55212 1/20 0.40
HSD17B10 Q99714 1/20 0.40
DHFR P00374 1/20 0.40
NQO2 P16083 1/20 0.40
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12278103 1.00 AKR1C3 (0.47) AKR1C3AKR1C2ATMENPP2G6PD
SCHEMBL12277502 0.90 HPRT1 (0.52) ATMLMNAPTGS2ALDH1A1HSD17B10
SCHEMBL12278221 0.88 AKR1C3 (0.46) AKR1C3AKR1C2ATMENPP2G6PD
SCHEMBL13561723 0.87 ATM (0.50) AKR1C3AKR1C2ATMLMNAPTGS2
SCHEMBL12508320 0.85 AKR1C3 (0.58) AKR1C3AKR1C2ATMENPP2G6PD
SCHEMBL12260045 0.84 DHFR (0.54) ENPP2PTGS2DHFR
SCHEMBL13203351 0.83 AKR1C3 (0.52) AKR1C3AKR1C2ATMENPP2G6PD
SCHEMBL12277758 0.83 ATM (0.50) AKR1C3AKR1C2ATMLMNAPTGS2
SCHEMBL12259998 0.78 GAA (0.45) SMN1; SMN2ALDH1A1CYP2C9CYP2C19CASP6
SCHEMBL16289810 0.78 CYP1A2 (0.55) ATMPTGS2ALDH1A1CASP6HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575599-B2 Compound for organic thin film transistor and organic thin film transistor using the same IDEMITSU KOSAN CO., LTD. (JP) 2013-11-05 US disclosed
US-8575599-B2 Compound for organic thin film transistor and organic thin film transistor using the same IDEMITSU KOSAN CO., LTD. (JP) 2013-11-05 US disclosed
US-20110220883-A1 COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-09-15 US disclosed
US-20110220883-A1 COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110220883-A1 COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME SLC43A1, OR10J3, ALKBH3 AKR1C3 422/4885AKR1C2 347/4885ATM 2790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.